Navigation Links
Where have all the Midwest VCs gone?

Since the dot-com boom days are over and soaring tech funds are long gone, where are investment firms putting their money? Whats their criteria for investing? What is their strategy?

If you are a start-up firm looking for investment capital, you may be surprised at how things have changed. In some cases, former self-proclaimed savvy investors have become gun shy to the point that theyre ......

Full article >>> they had all those criteria met. Instead, they would be self-sustaining.

So much for the rigid terms that some investment sources think theyre going to secure with the next group of candidates. Few are buying into it and it has gotten to a point where some start-up firms are seeking alternative investors over ones that are local. I have heard from several different companies that they a......

Full article >>> ech work going on in the Midwest. Some could argue that Wisconsin has a big jump on Illinois in terms of defining biotech as a new jobs creation industry. Illinois seems to lag behind.

Though politicians seem to think Illinois is a great place to encourage new endeavors, I think they are long on talk and short on action. Time will tell as outside funds line up to analyze new local produc......

Full article >>>
'"/>

Source:wistechnology.com By Jim Carlini 03/28/03


Related biology technology :

1. H-1B jobs: Where is the shortage of skilled workers?
2. Municipal broadband in Illinois: Where are the standards?
3. My-oh, its BIO! Where sales hype and science collide
4. Where will you be at BIO?
5. Where have all the angels gone?
6. Mobile content: Where brand meets markets
7. CAN-SPAM: Wheres the Meat?
8. Midwest life science stocks kept sizzling in Q2
9. Midwest life science stocks sizzle in a tepid first quarter
10. A Midwest passage to India, Part II
11. Midwest offers non-stop flight to North Carolina research park
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... new line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC ... in Chicago. The result of a collaboration among several companies with expertise in ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):